Search Results - "BRESOLIN, Nereo"
-
1
Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
Published in Cellular and molecular life sciences : CMLS (01-01-2021)“…Extracellular vesicles (EVs) are small reservoirs of different molecules and important mediators of cell-to-cell communication. As putative vehicles of…”
Get full text
Journal Article -
2
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
Published in Molecular neurobiology (01-07-2020)“…Although the pathogenesis of neurodegenerative diseases is still widely unclear, various mechanisms have been proposed and several pieces of evidence are…”
Get full text
Journal Article -
3
Neural Stem Cell Transplantation for Neurodegenerative Diseases
Published in International journal of molecular sciences (28-04-2020)“…Neurodegenerative diseases are disabling and fatal neurological disorders that currently lack effective treatment. Neural stem cell (NSC) transplantation has…”
Get full text
Journal Article -
4
Brain Mitochondria, Aging, and Parkinson's Disease
Published in Genes (11-05-2018)“…This paper reconsiders the role of mitochondria in aging and in Parkinson's Disease (PD). The most important risk factor for PD is aging. Alterations in…”
Get full text
Journal Article -
5
Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives
Published in Cellular and molecular life sciences : CMLS (01-11-2020)“…Noncoding RNAs (ncRNAs), such as miRNAs and long noncoding RNAs, are key regulators of gene expression at the post-transcriptional level and represent…”
Get full text
Journal Article -
6
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
Published in Journal of neurology (01-05-2021)“…The novel Coronavirus disease-19 (COVID-19) pandemic has posed several challenges for neuromuscular disorder (NMD) patients. The risk of a severe course of…”
Get full text
Journal Article -
7
Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?
Published in Neurobiology of disease (01-07-2020)“…Spinal muscular atrophy (SMA) is a severe, inherited disease characterized by the progressive degeneration and death of motor neurons of the anterior horns of…”
Get full text
Journal Article -
8
Preconditioning and Cellular Engineering to Increase the Survival of Transplanted Neural Stem Cells for Motor Neuron Disease Therapy
Published in Molecular neurobiology (01-05-2019)“…Despite the extensive research effort that has been made in the field, motor neuron diseases, namely, amyotrophic lateral sclerosis and spinal muscular…”
Get full text
Journal Article -
9
Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature
Published in International journal of molecular sciences (25-08-2019)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting upper and lower motor neurons (MNs) that still lacks an efficacious…”
Get full text
Journal Article -
10
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
Published in Scientific reports (13-04-2022)“…Charcot–Marie–Tooth disease type 2A (CMT2A) is a rare inherited axonal neuropathy caused by mutations in MFN2 gene, which encodes Mitofusin 2, a transmembrane…”
Get full text
Journal Article -
11
Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
Published in Clinical therapeutics (2014)“…Abstract Background Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by mutations in the survival motor neuron gene ( SMN1 )…”
Get full text
Journal Article -
12
Molecular Approaches for the Treatment of Pompe Disease
Published in Molecular neurobiology (01-02-2020)“…Glycogen storage disease type II (GSDII, Pompe disease) is a rare metabolic disorder caused by a deficiency of acid alpha-glucosidase (GAA), an enzyme…”
Get full text
Journal Article -
13
MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives
Published in Journal of the neurological sciences (15-09-2015)“…Abstract Mitofusin 2 (MFN2) is a GTPase dynamin-like protein of the outer mitochondrial membrane, encoded in the nuclear genome by the MFN2 gene located on the…”
Get full text
Journal Article -
14
MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis
Published in Journal of cellular and molecular medicine (01-03-2019)“…Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting upper and lower motor neurons (MNs), resulting in paralysis and…”
Get full text
Journal Article -
15
Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions
Published in The Journal of experimental medicine (08-06-2009)“…Many human genes have adapted to the constant threat of exposure to infectious agents; according to the "hygiene hypothesis," lack of exposure to parasites in…”
Get full text
Journal Article -
16
Mental health and coping strategies in families of children and young adults with muscular dystrophies
Published in Journal of neurology (01-07-2020)“…Background Living with a progressive disease as muscular dystrophy (MD) can be challenging for the patient and the entire family from both emotional and…”
Get full text
Journal Article -
17
MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
Published in Scientific reports (04-07-2018)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder that is characterized by a progressive degeneration of motor neurons (MNs). The…”
Get full text
Journal Article -
18
Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients
Published in Journal of cellular and molecular medicine (01-03-2020)“…The antisense oligonucleotide Nusinersen has been recently licensed to treat spinal muscular atrophy (SMA). Since SMA type 3 is characterized by variable…”
Get full text
Journal Article -
19
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
Published in Cellular and molecular life sciences : CMLS (01-09-2020)“…Spinal muscular atrophy (SMA) with respiratory distress type 1 (SMARD1) is an autosomal recessive motor neuron disease that is characterized by distal and…”
Get full text
Journal Article -
20
Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
Published in Therapeutic Advances in Neurological Disorders (2019)“…Duchenne and Becker muscular dystrophies are the most common muscle diseases and are both currently incurable. They are caused by mutations in the dystrophin…”
Get full text
Book Review Journal Article